Inventor · disambiguated record
Michael Frederick Snape
Also filed as: SNAPE MICHAEL · SNAPE MICHAEL FREDERICK
6 granted patents·6 pending applications·66 citations·filing 2001–2023
81Inventor score
Top patents by PatentIndex Score
12 records- 0187US6828318B22-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmissionVERNALIS RES LTD·Filed 2001·Granted Dec 7, 2004·48 cites·34 claims
- 0286US9212204B2Treatment of rett syndrome using glycyl-L-2-methylprolyl-L-glutamic acidNEUREN PHARMACEUTICALS LTD·Filed 2015·Granted Dec 15, 2015·8 cites·7 claims
- 0378US9708366B2Treatment of fragile X syndrome using glycyl-L-2-methylprolyl-L-glutamateGLASS LARRY·Filed 2012·Granted Jul 18, 2017·7 cites·19 claims
- 0477US9867823B2Neuroprotective bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disordersNEUREN PHARMACEUTICALS LTD·Filed 2016·Granted Jan 16, 2018·3 cites·19 claims
- 0567US2023241038A1Method of treating rna repeat mediated diseases with rna repeat binding compoundAMO PHARMA LTD·Filed 2023·Application pending·0 cites
- 0664US2022387399A1Method of treating rna repeat mediated diseases with rna repeat binding compoundAMO PHARMA LTD·Filed 2022·Application pending·0 cites
- 0761US11197856B2Bicyclic compounds and methods for their use in treating autismNEUREN PHARMACEUTICALS LTD·Filed 2020·Granted Dec 14, 2021·0 cites·24 claims
- 0858US2023270752A1Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinonesAMO PHARMA LTD·Filed 2023·Application pending·0 cites
- 0956US10548892B2Bicyclic compounds and methods for their use in treating autism spectrum disorders and neurodevelopmental disordersNEUREN PHARMACEUTICALS LTD·Filed 2018·Granted Feb 4, 2020·0 cites·30 claims
- 1046US2020330478A1Methods of treating phelan mcdermid syndrome using farnesyl dibenzodiazepinonesAMO PHARMA LTD·Filed 2018·Application pending·0 cites
- 1138US2015141380A1Inhibitors of erk for developmental disorders of neuronal connectivitySMITH MARK A·Filed 2011·Application pending·0 cites
- 1235US2015224164A1Treatment of autism spectrum disorders using glycyl-l-2-methylprolyl-l-glumatic acidNEUREN PHARMACEUTICALS LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Frederick Snape files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →